UK: GSK’s Pandemrix Swine Flu Vaccine - Pandora's Box Release

[Guest guest]

UK and also to be used in Canada - probably also will be approved in the

US

(Mailing list information, including unsubscription instructions, is

located at the end of this message.)

READ THE NEWS ON ONE CLICK

http://www.theoneclickgroup.co.uk

1.

GSK’s Pandemrix Swine Flu Vaccine - Pandora's Box Release

60 million doses GlaxoKline’s ‘Pandemrix’ H1N1 Swine Flu vaccine are

shortly to be let out of the box and guinea pig trialled on the UK

population including babies as young as 6 months and pregnant women. One

Click publishes GSK's Pandemrix Vaccine Patent filed in 2006, together

with the vaccine's CHMP Report and Product Information. These show that

largely untested and untrialled, the vaccine contains the thimerosal and

squalene adjuvants over which much concern has been raised. Serious

adverse events on this vaccine were reported but not detailed. To date

there have only been 80 swine-flu related deaths in the UK in 2009 and in

general, symptoms are not severe. It is irresponsible, unsafe and

inappropriate to begin mass vaccinating populations with a fast-tracked

vaccine with little or no testing or post-marketing surveillance in the

majority of the target population, and especially the under-18’s. The

only parties who stand to gain sign ificantly from this vaccination

programme at present are the vaccine manufacturers and GPs surgeries who

will receive a payment of £5.25 per dose of vaccine administered. GSK’s

timing in relation to the ‘swine flu’ outbreak, as with Baxter, was all

but perfect. The evidence contained in these Pandemrix vaccine documents

is devastating. Before you inject yourself or members of your family to

enrich GlaxoKline and the doctors, read it. One Click Note: To the

vasty majority of elected UK politicians subscribed to the One Click News

Alerts, you will never be able to say that you were not warned.

Lara, Health Advocate

Related